Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
6.99
+0.06 (0.87%)
At close: May 20, 2025, 4:00 PM
6.78
-0.21 (-3.00%)
After-hours: May 20, 2025, 4:10 PM EDT
Bioventus Market Cap
Bioventus has a market cap or net worth of $463.84 million as of May 20, 2025. Its market cap has increased by 83.05% in one year.
Market Cap
463.84M
Enterprise Value
807.16M
1-Year Change
83.05%
Ranking
Category
Stock Price
$6.99
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $463.84M, a decrease of -34.99%. That is a compound annual growth rate of -9.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 463.84M | -32.42% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |